David Rosmarin, MD

Trials

Studies that name David Rosmarin, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:33 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06561321 · Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma

  Indiana University · active not recruiting · Palmoplantar Keratoderma · principal investigator
• Ph2
  NCT04306965 · Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab

  Tufts Medical Center · completed · Atopic Dermatitis · principal investigator
• Ph2
  NCT04299503 · Topical Crisaborole in Patients with Alopecia Areata

  Tufts Medical Center · withdrawn · Alopecia Areata · principal investigator
• Early Ph1
  NCT03159936 · Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)

  Tufts Medical Center · terminated · Discoid Lupus Erythematosus, Systemic Lupus Erythematosus · principal investigator
• Early Ph1
  NCT03099980 · Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa

  Tufts Medical Center · completed · Hidradenitis Suppurativa · principal investigator
• Ph2
  NCT02809976 · Topical Ruxolitinib for the Treatment of Vitiligo

  Tufts Medical Center · completed · Vitiligo · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.